For research and educational purposes only. Not medical advice.

Teriparatide Reference

Educational, not medical advice reference for Teriparatide: Bone, Hormonal; regulatory status, evidence posture, source review, and schedule not…

Reference summary

Teriparatide is a label-verified prescription drug with decades of approved-label osteoporosis evidence. pepSmart surfaces label-reference content only and is not a prescribing tool.

Regulatory and posture

Categories
Bone, Hormonal
Aliases
Forteo, rhPTH(1-34), Parathyroid hormone 1-34
Evidence posture
human
Regulatory status
FDA-approved prescription medication (Forteo). Labeled for osteoporosis treatment in postmenopausal women and men at high risk of fracture, and for glucocorticoid-induced osteoporosis. Cumulative lifetime exposure (teriparatide plus abaloparatide) should not exceed 2 years per label.
Content review status
label verified

Selected public sources

Related tools